Search

Search Constraints

You searched for: Author/Creator Davis, Mitchell

Search Results

2. High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award: 868. (October 2016)

4. Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study. Issue 2 (22nd March 2016)

5. Sustained Virologic Response Predicts Fibrosis Regression Measured by FibroTest in HCV‐infected Patients: 828. (October 2016)